The Incidence of Osteonecrosis of the Jaw in Patients Receiving 5 Milligrams of Zoledronic Acid-Reference-Cited by-同舟云学术

The Incidence of Osteonecrosis of the Jaw in Patients Receiving 5 Milligrams of Zoledronic Acid

Published:2010-11 Issue:11 Volume:141 Page:1365-1370
ISSN:0002-8177
Container-title:The Journal of the American Dental Association
language:en
Short-container-title:The Journal of the American Dental Association

Author:

Grbic John T.,Black Dennis M.,Lyles Kenneth W.,Reid David M.,Orwoll Eric,McClung Michael,Bucci-Rechtweg Christina,Su Guoqin

Publisher

Elsevier BV

Subject

General Dentistry

Reference15 articles.

1. Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research;Khosla;J Bone Miner Res,2007

2. Systematic review: bisphosphonates and osteonecrosis of the jaws (published correction appears in Ann Intern Med 2006;145[3]:235);Woo;Ann Intern Med,2006

3. Incidence of osteonecrosis of the jaw in women with postmenopausal osteoporosis in the health outcomes and reduced incidence with zoledronic acid once yearly pivotal fracture trial;Grbic;JADA,2008

4. Zoledronic acid and clinical fractures and mortality after hip fracture;Lyles;N Engl J Med,2007

Cited by 97 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Narrative Review of Osteonecrosis of the Jaw: What a Clinician Should Know;Cureus;2023-12-27

2. Idiopathic avascular maxillary necrosis: A case report;Oral and Maxillofacial Surgery Cases;2023-12

3. Call to action: a five nations consensus on the use of intravenous zoledronate after hip fracture;Age and Ageing;2023-09-01

4. Anti-resorptive therapy in the osteometabolic patient affected by periodontitis. A joint position paper of the Italian Society of Orthopaedics and Traumatology (SIOT) and the Italian Society of Periodontology and Implantology (SIdP);Journal of Orthopaedics and Traumatology;2023-07-15

5. Risk comparison of osteonecrosis of the jaw in osteoporotic patients treated with bisphosphonates vs. denosumab: a multi-institutional retrospective cohort study in Taiwan;Osteoporosis International;2023-06-16